Users and beneficiaries given 3 months to adjust drug payment contributions or face up to 1,500 EUR fine
Technical details
Type
Act (what is this?)
Identifier
BOE-A-2026-10324
Published
13 May 2026
Entry into force
4 Aug 2026 · in 29 days
Summary
The regulation amends Article 102 of RDL 1/2015 to introduce a three-month period for users and beneficiaries to adjust their contributions, with a maximum fine of 1,500 euros for non-compliance. This aims to enhance transparency and accountability in pharmaceutical care financing.
Lifecycle
2026-05-13PublishedPublished in the BOE
2026-08-04Into forceComes into force (disposicion final segunda)
BMC resources for this provision
- relaciones-laboralesView service →
- coste-empleadoCalculatorOpen →
Official text Based on BOE data (boe.es). Information, not advice.